On August 1, 2024, the U.S. Food and Drug Administration (FDA) announced the 10 members of its new Digital Health Advisory Committee. The Digital Health Advisory Committee is tasked with advising the FDA on policies related to artificial intelligence(AI)/machine learning, cybersecurity, patient-generated health data, and other digital health technologies. The Committee’s first meeting will be held over two days on November 20-21, 2024, and will focus on the impact of generative AI-enabled devices on the safety and effectiveness of medical devices. The Digital Health Advisory Committee includes:
- Chairperson Ami Bhatt, M.D., Chief Innovation Officer at American College of Cardiology
- Designated Federal Officer James Swink
- Ray Dorsey, M.D. M.B.A, pr
- Yaniv Kerem, M.D., p
- Joyce C. Ho, Ph.D., Associate Professor of Computer Science at Emory University.
- Jessica L. Jackson, Ph.D., Founder and CEO of Therapy Is For Everyone
- Thomas M. Maddox, M.D., SM, Professor of Medicine (cardiology) at Washington University School of Medicine
- Chevon M. Rariy, M.D., Chief Health Officer and Senior Vice President of Digital Health for Oncology Care Partners
- Laura M. Stanley, Ph.D., CPE, Associate Professor at Montana State University School of Computing
- Melissa Denise Clarkson, Ph.D., Assistant Professor at University of Kentucky College of Medicine (consumer representative)
Learn more here.
Last Updated on August 8, 2024 by Aimed Alliance
